NCT07382323 Metacognitive Therapy Compared to Cognitive-behavioral Therapy
| NCT ID | NCT07382323 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karolinska Institutet |
| Condition | Generalized Anxiety Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-01-28 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-01-28 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older, * A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder, * No change in dose during the last six weeks if on pharmacological treatment, and * Ability to read and speak Swedish. Exclusion Criteria: * A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder, * Acute suicide risk, or * Concurrent psychological treatment.
Contact & Investigator
Benjamin Bohman
PRINCIPAL INVESTIGATOR
Karolinska Institutet
Frequently Asked Questions
Who can join the NCT07382323 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Generalized Anxiety Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07382323 currently recruiting?
Yes, NCT07382323 is actively recruiting participants. Contact the research team at benjamin.bohman@ki.se for enrollment information.
Where is the NCT07382323 trial being conducted?
This trial is being conducted at Stockholm, Sweden.
Who is sponsoring the NCT07382323 clinical trial?
NCT07382323 is sponsored by Karolinska Institutet. The principal investigator is Benjamin Bohman at Karolinska Institutet. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.